共 19 条
- [4] Jurczak MJ, 2011, DIABETES, V60, P890, DOI 10.2337/db10-1328
- [5] A randomized, double-blind, placebo-controlled study on long-term efficacy and safety of ipragliflozin treatment in patients with type 2 diabetes mellitus and renal impairment: results of the Long-Term ASP1941 Safety Evaluation in Patients with Type 2 Diabetes with Renal Impairment (LANTERN) study [J]. DIABETES OBESITY & METABOLISM, 2015, 17 (02) : 152 - 160